Your browser doesn't support javascript.
loading
Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression.
Deng, Davy; Hammoudeh, Lubna; Youssef, Gilbert; Chen, Yu-Hui; Shin, Kee-Young; Lim-Fat, Mary Jane; McFaline-Figueroa, Jose Ricardo; Chukwueke, Ugonma N; Tanguturi, Shyam; Reardon, David A; Lee, Eudocia Q; Nayak, Lakshmi; Bi, Wenya Linda; Arnaout, Omar; Ligon, Keith L; Wen, Patrick Y; Rahman, Rifaquat.
Afiliación
  • Deng D; Massachusetts Institute of Technology, Harvard University, Boston, Massachusetts, USA.
  • Hammoudeh L; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Youssef G; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.
  • Chen YH; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.
  • Shin KY; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Lim-Fat MJ; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts¸USA.
  • McFaline-Figueroa JR; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Chukwueke UN; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Tanguturi S; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.
  • Reardon DA; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.
  • Lee EQ; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Nayak L; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.
  • Bi WL; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.
  • Arnaout O; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.
  • Ligon KL; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Wen PY; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
  • Rahman R; Department of Pathology, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
Neurooncol Adv ; 5(1): vdad083, 2023.
Article en En | MEDLINE | ID: mdl-37554224
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos